This HTML5 document contains 115 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q46953060
rdf:type
wikibase:Item
schema:description
artykuł naukowy 2017年学术文章 artikull shkencor bài báo khoa học 2017年学术文章 artículu científicu scientific article published on 14 March 2017 teaduslik artikkel מאמר מדעי 2017年学术文章 naučni članak 2017年学术文章 artikel ilmiah artigo científico научная статья 2017年の論文 tieteellinen artikkeli article scientifique article scientific 2017年学术文章 2017年學術文章 articol științific 2017年學術文章 wissenschaftlicher Artikel scientific article published on 14 March 2017 artigo científico vědecký článek vedecký článok 2017年學術文章 vitenskapelig artikkel научни чланак บทความทางวิทยาศาสตร์ ১৪ মার্চ ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2017年学术文章 vetenskaplig artikel научна статия article científic 2017 nî lūn-bûn 2017年學術文章 мақолаи илмӣ articolo scientifico artículo científico publicado en 2017 artikulong pang-agham 2017年學術文章 videnskabelig artikel مقالة علمية نشرت في 14 مارس 2017 vitskapeleg artikkel 2017년 논문 scientific article published on 14 March 2017 სამეცნიერო სტატია artigo científico scienca artikolo bilimsel makale επιστημονικό άρθρο наукова стаття, опублікована в березні 2017 wetenschappelijk artikel научни чланак tudományos cikk
p:P577
wds:Q46953060-F0F0B8B8-4FDF-4A8C-9653-316459F924E0
wdt:P577
2017-03-14T00:00:00Z
p:P407
wds:Q46953060-A00826CA-1712-4AFB-9AED-D517A6986BD6
wdt:P407
wd:Q1860
p:P2093
wds:Q46953060-AAD7329C-48DC-4234-B5D4-2836B6F1D728 wds:Q46953060-AC3F2D37-B142-42C3-B3A0-FEADA141C26C wds:Q46953060-8E720217-1236-4E84-83EE-3D5EAD70D2DF wds:Q46953060-7333B437-EAA3-4785-B659-73E1F9B86AC4 wds:Q46953060-3B283A8F-1BAD-47E8-8006-D4C768A46752 wds:Q46953060-36BF60E2-25A4-450C-82A6-E76A14A74641 wds:Q46953060-230EFF08-817C-40F7-B9AB-3509C7277D2A wds:Q46953060-F6C3C867-4E66-4493-8E8A-E082607F952B wds:Q46953060-D0785EFB-A598-47CE-9553-FDD2E378FF9A wds:Q46953060-B6D41349-1390-43FC-AA9E-443046553D6E wds:Q46953060-C5A6DAD6-395A-4E27-8690-081B7D7CB522 wds:Q46953060-B3CABED9-D2C8-4651-8370-3E959CEE82EA
wdt:P2093
Johann S de Bono Neal D Shore Matthew R Smith Margaret K Yu Jinhui Li Thian Kheoh Dana E Rathkopf Mary B Todd Peter F A Mulders Charles J Ryan Peter De Porre Eric J Small
rdfs:label
Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
skos:prefLabel
Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
schema:name
Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
p:P50
wds:Q46953060-57CD3122-37A0-48BC-B1B5-84798D129B4A wds:Q46953060-153E0642-F21A-405F-9A23-8FA772E2F8BC
wdt:P50
wd:Q88065306 wd:Q73569107
p:P1476
wds:Q46953060-FE712693-FB6E-456D-AB70-840431099D3C
wdt:P1476
Clinical Outcomes from Androgen Signaling-directed Therapy after Treatment with Abiraterone Acetate and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302.
p:P304
wds:Q46953060-2C31CF22-42B1-4200-AF7F-0FECA53C4C30
wdt:P304
10-13
p:P31
wds:Q46953060-6A2FF3C4-1FB7-4464-9DFC-84F9150AD293
wdt:P31
wd:Q13442814
p:P698
wds:Q46953060-E703A299-D3CB-4E88-BE14-4AB09CC4EB3F
wdtn:P698
n10:28314611
wdt:P698
28314611
p:P1433
wds:Q46953060-0AE3470A-8FB4-47F4-8C4F-F6057570A864
wdt:P1433
wd:Q15763991
p:P433
wds:Q46953060-B5D95C9D-17F1-4235-8A3F-77A033BAA1DB
p:P478
wds:Q46953060-AA5978A8-A4FB-401C-84D0-46B7717B745E
wdt:P433
1
wdt:P478
72
p:P356
wds:Q46953060-78826414-0D8E-48EC-9622-3C0A2A100E1B
wdtn:P356
n9:J.EURURO.2017.03.007
wdt:P356
10.1016/J.EURURO.2017.03.007